Clinical Expert
Icon Oncology pioneers use of Varian’s RGSC system
Respiratory gating system and software - first in South Africa rolled-out Leading cancer care business, Icon Oncology is proud to announce the first implementation in South Africa of a new respiratory gating system. This new system is designed to increase accuracy and...
News Highlight
Icon Oncology grants to provide better access to cancer care
Application for oncology stakeholders now open South Africa’s foremost provider of private oncology services has launched a grant initiative to provide cancer patients with better access to cancer care. Icon Oncology Holdings today announced the project aimed at...
Business News
Debating The Future Of Oncology – 2022 Icon Oncology Conference
Pioneering the Right Care The future of oncology in South Africa will be in the spotlight at the first Icon Oncology Conference since the global Covid pandemic. The theme for the Sixth Icon Conference is “Pioneering the Right Care”, and it convenes in early...
Patient Testimonial
Mediclinic Southern Africa, Icon Oncology and Cancercare celebrate a first in oncology.
Cape Town, 16 August: Mediclinic Southern Africa, Icon Oncology and Cancercare today celebrated a first in South Africa with the official opening of a new flagship treatment facility based at Mediclinic Constantiaberg in Cape Town. The brand new R45-million oncology...
Innovation
Icon Oncology pioneers use of Varian’s RGSC system
Respiratory gating system and software - first in South Africa rolled-out Leading cancer care business, Icon Oncology is proud to announce the first implementation in South Africa of a new respiratory gating system. This new system is designed to increase accuracy and...
CSI
Icon Oncology grants to provide better access to cancer care
Application for oncology stakeholders now open South Africa’s foremost provider of private oncology services has launched a grant initiative to provide cancer patients with better access to cancer care. Icon Oncology Holdings today announced the project aimed at...